| Date | Title | Description |
| 02.09.2026 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | Sept 2 : AI company Owkin said on Wednesday it has signed a licensing deal with Germany's Boehringer Ingelheim, giving the drugmaker access to its AI research platform and patient data to speed up discovery of drugs for cancer and immunity-... |
| 30.07.2026 | Данные любят конфиденциальность | Данные любят конфиденциальность Почему экосистемы пересматривают подход к сбору и анализу данных в 2026 году
Рост экосистем в России сделал лидеров рынка главными после государства держателями данных. Однако при объединении большого количес... |
| 01.06.2026 | Geordie AI Secures $30M to Fortify Enterprise AI Security and Governance | Geordie AI secured $30M in Series A funding, led by Balderton Capital, to bolster its AI agent security platform. Enterprises rapidly adopt agentic AI but face governance gaps. Geordie provides critical tools for safe, scalable AI deploymen... |
| 31.05.2026 | Geordie AI: $30 Million Series A Raised To Help Enterprises Govern Autonomous AI Agents | Geordie AI (see Pulse 2.0 profile here) announced it has raised $30 million in Series A funding led by Balderton Capital, with participation from existing investors General Catalyst and Ten Eleven Ventures, as well as new investor Crosspoin... |
| 28.05.2026 | Geordie Raises $30M to Help Enterprises Securely Adopt Agentic AI at Scale | the purpose-built security and governance platform for AI agents, today announced it has closed a $30 million Series A round led by Balderton Capital. The round included participation from Crosspoint Capital, as well as follow-on investment... |
| 19.04.2026 | Modern Relay Secures $3M to Unify Enterprise AI Operations | Modern Relay, an AI infrastructure innovator, recently closed a $3 million funding round. This capital infusion will accelerate the development of a critical shared operational layer for enterprise AI agents. Organizations grapple with frag... |
| 14.04.2026 | Modern Relay raises $3M to build shared infrastructure layer for AI agents in the enterprise | Modern Relay today announced a $3 million funding round from Point Nine, Emerge, Amino Collective, Common Magic, and angels, including Charlie Songhurst (board member at Meta), Michael Boehler (former BioNTech executive), and Thomas Clozel ... |
| 13.03.2026 | Waiv Secures $33 Million to Revolutionize Cancer Diagnostics with AI | Waiv, an AI precision testing innovator, recently secured $33 million in funding. This Paris-based company spun out from Owkin. It transforms cancer diagnostics. Waiv's powerful AI analyzes digital histopathology and multimodal clinical dat... |
| 12.03.2026 | Waiv: $33 Million Financing For AI-Powered Precision Testing Spinout From Owkin | Owkin announced the spinout of Waiv, formerly known as Owkin Dx, alongside $33 million in financing led by OTB Ventures and Alpha Intelligence Capital.
The new company is focused on developing AI-powered precision testing to better identify... |
| 12.03.2026 | Waiv Secures $33 Million to Scale AI Precision Testing | Waiv, a Paris-based company catalyzing AI precision testing, today announced a $33 million financing round to accelerate the global deployment of its AI precision testing platform. The financing marks Waiv’s spin out from Owkin, where its e... |
| 12.03.2026 | Waiv: $33 Million Raised For AI Precision Oncology Testing Platform | Waiv, a Paris-based developer of AI-powered precision oncology testing technology, announced it has raised $33 million in financing to accelerate global deployment of its AI precision testing platform and expand its clinical-grade diagnosti... |
| 09.03.2026 | Healthcare AI pilots outpace sector's regulatory readiness | - |
| 26.01.2026 | [Opinion] 2026: The Dawn of AI-Driven Drug Development | (Yicai) Jan. 23 -- The next big leap for artificial intelligence in healthcare is no longer in the lab, but in clinical trials -- where drug development succeeds or fails.
For years, the conversation around AI in healthcare has been dominat... |
| 19.12.2025 | The rise and impact of AI in Biotechnology and Healthcare | - |
| 17.12.2025 | Bioptimus Unveils M-Optimus, a World Model for Biology | Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation
The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model fo... |
| 15.12.2025 | Corma Secures €3.5M Seed Funding to Tackle Software Sprawl | Corma, a Paris-based SaaS management platform, just raised €3.5 million. The seed round was led by XTX Ventures. Tuesday Capital, Kima Ventures, and others participated. Funding fuels product development, AI integration, and expansion. Comp... |
| 09.12.2025 | Corma: €3.5 Million Seed Funding Closed To Advance Software License And Access Governance | Corma, a Paris-based SaaS management platform focused on helping IT teams control rapidly growing software portfolios, has raised €3.5 million in seed funding to accelerate product development, expand its AI capabilities, and scale its comm... |
| 31.10.2025 | Paris-based Altrove raises $10M to accelerate AI-designed alternatives to critical materials | Paris-based deeptech Altrove has raised $10 million in seed funding to scale production of AI-designed, sustainable alternatives to critical materials such as rare earths.
The round was led by Alven, with participation from Bpifrance’s Digi... |
| 02.10.2025 | So macht Venture Capital die Industrie zukunftsfähig | Der Begriff “Deindustrialisierung” ist in den letzten Monaten zum festen Bestandteil wirtschaftspolitischer Debatten geworden. Steigende Energiekosten, globaler Wettbewerb und der Rückzug großer Produktionsstandorte machen deutlich: Deutsch... |
| 19.09.2025 | The new €18 million Polish fund vastpoint has just launched, led by ex-entrepreneurs from ElevenLabs and Y Combinator | Warsaw’s vastpoint, a new VC firm, is launching today with €18 million and a mission to back Poland’s most ambitious early-stage tech Founders with Seed investments – leveraging its dual presence in Warsaw and New York to connect startups w... |
| 27.05.2025 | Cathay Innovation: $1 Billion VC Fund Closed | Cathay Innovation announced today the final close of its latest venture capital fund at $1 billion, making it the largest AI-focused fund in the European Union.
The closing of this fund marks a significant shift in AI-era venture capital, w... |
| 12.02.2025 | The Rise of Federated Learning: A New Era in Data Privacy and Machine Learning | In a world where data is the new oil, privacy is the gold standard. Federated Learning (FL) emerges as a beacon of hope, allowing organizations to harness the power of machine learning without compromising sensitive information. Imagine a g... |
| 07.02.2025 | Федеративное обучение: учимся вместе, не раскрывая секретов | Как обучать ML-модели на большом объеме данных из разных источников, сохраняя их конфиденциальность? Ответ — федеративное машинное обучение (Federated Learning, или FL). Эксперт простыми словами на примерах рассказывает, что это такое, как ... |
| 31.01.2025 | Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395 | What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced sol... |
| 02.10.2024 | LetsGetChecked finalizes acquisition of Truepill | Photo: d3sign/Getty Images
At-home diagnostics company LetsGetChecked announced it has finalized its acquisition of digital pharmacy and telehealth startup Truepill.
LetsGetChecked offers at-home tests for sexual health, diabetes, thyroid, ... |
| 02.10.2024 | Owkin Partners with AstraZeneca for Advanced AI gBRCA Pre-Screening | Share
Tweet
Share
Share
Email
Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer.
Takeaway Points Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast canc... |
| 19.09.2024 | Astamuse Co., Ltd. The cutting edge of privacy enhancement technology: The future seen through research and development and patents | [Astamuse Co., Ltd.] The cutting edge of privacy enhancement technology: The future seen through research and development and patents
*Astamuse Co., Ltd.*
Press release: September 19, 2024
**
Cutting-edge privacy enhancement technology: The... |
| 13.08.2024 | Grand Winners Announced in 2024 Stevie® Awards for Technology Excellence | Amazon/Amazon Web Services wins the Grand Stevie as the most honored organization in the 2024 competition. The Grand Stevie for the Highest-Rated Nomination of the Year goes to Owkin.
Amazon and Owkin named top winners of the year
FAIRFAX, ... |
| 21.02.2024 | Bioptimus: Pioneering AI in Biology | Bioptimus, a Paris-based biotech startup, has secured a hefty $35 million in seed funding to propel its groundbreaking AI foundational model focused on biology. Led by CEO Jean-Philippe Vert, the company aims to revolutionize scientific res... |
| 20.02.2024 | Bioptimus raises $35 million seed round to develop AI foundational model focused on biology | There’s a new generative AI startup based in Paris. But what makes Bioptimus interesting is that it plans to apply everything we’ve collectively learned about AI models over the past few years with a narrow, exclusive focus on biology.
The ... |
| 20.02.2024 | Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model | As the French startup ecosystem continues to boom — think Mistral, Poolside, and Adaptive — today the Paris-based Bioptimus, with a mission to build the first universal AI foundation model for biology, emerged from stealth following a seed ... |
| 09.02.2024 | Owkin Teams Up with AWS to Advance Generative AI for Precision Medicine | Owkin selects Amazon Web Services (AWS) as its primary cloud provider to develop generative AI applications and accelerate drug discovery and development
Owkin, a TechBio that combines the best of human and artificial intelligence to find t... |
| 19.12.2023 | Owkin Enters Collaboration Agreement With MSD to Develop AI-powered Diagnostics for Cancer | Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer.
Owkin, a French-American biotechnology company that applies artificial int... |
| 21.06.2023 | Sanofi Goes All-In On AI | Chief Executive Officer of French pharmaceutical giant Sanofi, Paul Hudson, Paris, September 8, ... [+] 2021. (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images)AFP via Getty Images |
| 17.05.2023 | Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis | AI Biotech Owkin, a leading provider of AI-powered solutions for drug discovery and clinical development, has received a letter of support from the European Medicines Agency (EMA) regarding their proposed statistical adjustment on deep lear... |
| 01.05.2023 | A deep tech investor predicts these 3 AI startups will become the decacorns of this decade with valuations of over $100 billion | Amir Khan thinks that there will be a significant increase in AI and machine learning technologies in the commercial sector by 2030. OpenAI
Redeem now
Amir Khan is a deep tech investor who's known about ChatGPT for 10 years.
He lists three ... |
| 01.05.2023 | A deep tech investor predicts these 3 AI startups will become the decacorns of this decade with valuations of over $100 billion | Amir Khan is a deep tech investor who's known about ChatGPT for 10 years.
He lists three startups he wishes he had invested in years ago.
Advertisement
As a venture capitalist in the deep tech sector and the managing partner at MARL Acceler... |
| 31.03.2023 | Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases | - |
| 30.03.2023 | French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment | Paris-based AI biotech unicorn Owkin has launched a €33million AI-powered precision medicine project, PortrAIt which has been backed by the French Government.
The collaboration will see France’s best research hospitals working with Owkin an... |
| 19.01.2023 | Federated learning AI model could lead to healthcare breakthrough | Check out all the on-demand sessions from the Intelligent Security Summit here.
The potential for artificial intelligence (AI) and machine learning (ML) to improve human health cannot be understated, but it does face challenges.
Among the b... |
| 19.12.2022 | 33 healthcare and biotech startups investors expect to take off in 2023 | MedArrive; Alma; Abridge; Gilboa Therapeutics; Wheel; OneOncology; Capital Rx; Turquoise Health; Anna Kim/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
We asked top healthcare a... |
| 28.10.2022 | Newsletter October 2022 – Steps forward during Breast Cancer Awareness Month | Newsletter October 2022 – Steps forward during Breast Cancer Awareness Month
Fri, Oct 28, 2022 10:30 CET Report this content
This October is Breast Cancer Awareness Month, known for the Pink Ribbon, a campaign to raise awareness about the i... |
| 27.10.2022 | Owkin appoints Alban de La Sablière as Chief Business Officer | Originally published by OWKIN
AI biotech company Owkin has appointed Alban de La Sablière, formerly SVP Global Head of Partnering at Sanofi, as Chief Business Officer.
At Owkin, Alban will lead the scaling of the company’s commercial an... |
| 12.10.2022 | Resonance is a new $150 million VC fund based in Paris | There’s a new VC fund in town — at least if you live in Paris. Meet Resonance, a new $150 million fund (€150 million) backed 100% by Otium Capital.
You may already be familiar with Otium Capital. It is Pierre-Edouard Stérin’s family office.... |
| 07.10.2022 | Sanofi's BD chief heads to Owkin as CBO; Roche relies on its bench for Thomas Schinecker’s diagnostics replacement | Alban de La Sablière
Up until recently, Alban de La Sablière was Sanofi’s chief dealmaker, reporting directly to CEO Paul Hudson without officially being a C-suite executive.
That’s now changed with de La Sablière’s newe... |
| 04.10.2022 | Sanofi exec jumps to Owkin to ramp up the AI biotech’s pharma partnership plans | As Sanofi’s top business partnering executive, Alban de La Sablière led the pharmaceutical giant’s collaboration talks with numerous companies, including $30 billion in acquisitions in the past six years. Now he’s moving to the other end of... |
| 06.09.2022 | 6 AI companies disrupting healthcare in 2022 | Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.
Investments in AI-enabled healthcare have exploded over the past few years. But even with belt-tightening in 2022, digi... |
| 08.06.2022 | French AI biotech startup Owkin gets $80-million shot from Bristol Myers Squibb to accelerate drug development | Parisian AI biotech unicorn Owkin has brought in $80 million as it partners with the US-based pharmaceutical giant Bristol Myers Squibb on drugs trials. The new partnership could be transformational for patient outcomes and scientific progr... |
| 02.03.2022 | Alliance for Artificial Intelligence in Healthcare Elects New Board Leadership for 2022 | “AI will continue to have a demonstrable impact on human health. Having spent the last three years ideating with my fellow charter members to establish AAIH, I’m honored to take the reins and thrilled I get to engage with an incredible team... |
| 22.11.2021 | Owkin secures $180M Series B | Pharma giant Sanofi has made an equity investment worth $180 million in French-American startup Owkin, an AI and precision medicine company. The round includes $90 million over the next three years, plus additional payments based on researc... |
| 19.11.2021 | Sanofi makes $270M bet that a startup’s AI tech can boost its cancer drug R&D | Sanofi wants to see how digital technologies can improve its cancer drug research and it’s committing $270 million to artificial intelligence and precision medicine startup Owkin to begin a multi-drug alliance.
Under the deal, Sanofi will u... |
| 19.11.2021 | AI-based biotech startup Owkin becomes France’s new ‘unicorn’ after raising €159M from Sanofi | French and US-based Owkin, a startup that provides machine learning to allow medical researchers to test AI models on distributed data, has raised $180M (approx €159M) in a fresh round of funding. With a valuation of more than $1B, Owkin ha... |
| 18.11.2021 | Drugmaker Sanofi invests $180 million in French AI startup Owkin | The deal gives Sanofi a stake between 10 and 15% in Owkin, company co-founder and CEO Thomas Clozel said, and turns Owkin into a "unicorn" -- a startup company valued at more than $1 billion.
The transaction, steered by Sanofi's c... |
| 18.11.2021 | Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects | - |
| 18.11.2021 | Drugmaker Sanofi Invests $180m in French AI Startup Owkin | Originally published by Reuters
Drugmaker Sanofi is investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development of new cures against cancer, the Paris-based group said on Thursday... |
| 18.11.2021 | OWKIN, INC. announced that it has received $180 million in funding from Sanofi | OWKIN, INC. announced that it has received $180,000,000 in a round of funding on November 18, 2021. The transaction included participation from new investor Sanofi. The round is raised at a post-money valuation of $1,000,000,000. |
| 18.11.2021 | Drugmaker Sanofi invests $180 million in French AI startup Owkin | By Mathieu Rosemain
PARIS (Reuters) - Drugmaker Sanofi is investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development of new cures against cancer, the Paris-based group said on Thu... |
| 18.11.2021 | Drugmaker Sanofi invests $180 mln in French AI startup Owkin | - |
| 17.10.2021 | How AI is helping to make breast cancer history | Thomas Clozel Contributor
Share on Twitter
Thomas Clozel, M.D., is co-founder and CEO of Owkin, former assistant professor of clinical onco-hematology at Hôpital Henri-Mondor in Paris, and former member of the Melnick Lab at Weill Cornell M... |
| 15.10.2021 | AI Can Predict Risk of Recurrence for Women with Common Breast Cancer | Originally published by Pharmacy Times
A study from Gustave Roussy and the startup Owkin shows that deep learning analysis in digitized pathology slides can help classify patients with localized breast cancer between high- and low-risk of ... |
| 24.08.2020 | These 10 ambitious French tech startups obtained highest VC funding in Q2 2020 | Undoubtedly, the COVID-19 pandemic outbreak has impacted several businesses across the world causing an economic downturn. And, many early-stage businesses and startups have faced the worst dent in their operations forcing them to layoff em... |
| 01.07.2020 | Decentralized research platform Owkin raises another $18M for series A | “The idea of the federated learning technology is to allow researchers to collaborate on project without having to aggregate data into a consortium or a specific setting,” said Anna Huyghues-Despointes, Owkin’s head of strategy. “Our plan i... |
| 01.07.2020 | French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative | - |
| 30.06.2020 | French-American AI Startup Owkin Closes $18 million Series A to Make Medical Research More Collaborative | Originally published on Tech.EU
Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank’s Large Venture fund. This Series A extension b... |
| 30.06.2020 | French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative | Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank’s Large Venture fund. This Series A extension brings the startup’s total amount ... |
| 30.06.2020 | Owkin grabs $18M more in Series A funding, bringing its round total to $70M | |
| 30.06.2020 | Rubius marks milestone in PhI/II as CFO departs; Owkin closes $70M Series A; The Carlyle Group bets on Indian CDMO | → Some of the folks at Rubius Therapeutics weren’t too keen about our lede on the Takeda gene therapy story, which referenced their R&D mishaps. So they flagged another release out this morning, which highlights that the ... |
| 08.05.2020 | Owkin Raises $25m as it Builds a Secure Network for Healthcare Analysis and Research | Originally published by TechCrunch
Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data.
That’s the dream of ... |
| 08.05.2020 | Owkin lands $25M for AI-powered research platform, Braid Health scores $9M for teleradiology and more digital health funding | |
| 07.05.2020 | Owkin raises $25 million as it builds a secure network for healthcare analysis and research | Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data.
That’s the dream of the new New York-based startup Owkin,... |
| 07.05.2020 | Owkin raises $25 million as it builds a secure network for healthcare analysis and research | - |
| 08.03.2019 | Term Sheet — Friday, March 8 | MEET THE DEALMAKERS
We all know the stats. Only 2% of venture funding went to female founders, and just 8% of partners at the top venture capital firms are women. But in honor of International Women’s Day, I decided to highlight something e... |
| 08.03.2019 | Daily funding roundup - March 8th, 2019 | Bid Ops raised $1.75M; Jargon raised $1.8M; DesireList raised $3M; Osano raised $3M
Bid Ops: Bid Ops accelerates business partnerships between leading buyers and top suppliers. Bid Ops has raised $1.75 million in seed funding co-led by Illu... |
| 07.03.2019 | Owkin Closes New Round Led by F-Prime | Owkin, a NYC-based company which builds machine learning technologies and infrastructure to enable medical research, received a funding round of undisclosed amount.
The round was led by F-Prime Capital and Eight Roads Ventures, joined by GV... |
| 13.12.2018 | OWKIN initiates AI research network made up of 44 organizations | The overall aim is to advance knowledge sharing, preserve patient privacy and help create better patient outcomes.
A few projects made possible by the network include predicting brain age from MRIs and training a predictive model that pinpo... |
| 07.08.2018 | Which New York City healthcare companies raised the most dough from investors in Q2? | Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million.
Aetion, which focuses on real-world data through the science and analytics platform i... |
| 24.05.2018 | Alphabet's GV invests $5 million in AI startup Owkin | |
| 24.05.2018 | Owkin Received Additional Funding from GV; Raises $18M To-Date | Owkin, a NYC-based AI startup that uses machine learning to augment medical and biology research, closed an additional Series A funding.
The extension with GV raised the total to $18m to-date.
The company intends to use the funds to scale i... |
| 23.05.2018 | GV invests in medical machine learning startup Owkin | Owkin, a medical research machine learning startup, has announced a new investor in the form of GV (formerly Google Ventures), which has now joined as a late entrant to Owkin’s series A round.
Founded in 2016, Owkin’s platform leverages dee... |
| 23.05.2018 | GV Provides Funding to AI Startup Owkin | OWKIN, the AI startup that uses machine learning to augment medical and biology research, today announced it has closed an additional Series A investment round extension with GV, raising a total of $18 million to-date.
The capital raised wi... |
| 23.05.2018 | GV Provides Funding to AI Startup Owkin | OWKIN, the AI startup that uses machine learning to augment medical and biology research, today announced it has closed an additional Series A investment round extension with GV, raising a total of $18 million to-date.
The capital raised wi... |
| 23.05.2018 | GV invests in medical machine learning startup Owkin | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Owkin, a medical research machine learning startup, has announced a new investor in the form of GV (formerly Google Ventures), which ha... |
| 18.01.2018 | Medical data analysis startup OWKIN raises $11 million | OWKIN, a French predictive analytics company working on medical data, has raised $11 million in funding led by Otium Venture. Cathay Innovation, Plug and Play, and NJF Capital also participated in the Series A round.
The company develops OW... |
| 17.01.2018 | Term Sheet — Wednesday, January 17 | 5 Qs WITH A DEALMAKER
Krishna Yeshwant is not your typical VC. In addition to practicing internal medicine, Yeshwant is a general partner at GV (formerly Google Ventures), where he heads the Life Sciences team. His portfolio includes compan... |
| 16.01.2018 | OWKIN Receives $11M |
NEW YORK, NY, OWKIN, a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, today announced a $11 million Series A funding round.
>> Click here for more funding data on OWKIN
&... |
| 16.01.2018 | OWKIN Closes $11 Million Series A Financing Round | Otium Capital leads Series A round with participation from Cathay Innovation, Plug and Play and NJF Capital.
Funding will expand OWKIN Socrates, the first data driven discovery platform for clinical research.
NEW YORK – January 16, 2018 – O... |
| 16.01.2018 | OWKIN Closes $11 Million Series A Financing Round | NEW YORK--(BUSINESS WIRE)--OWKIN, a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, today announced a $11 million Series A funding round, led by Otium Venture with participation fro... |
| 16.01.2018 | Owkin Closes $11M Series A Financing Round | Owkin, a NYC-based predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, raised $11m in Series A funding.
The round, which brings total financing to $13.1m, was led by Otium Venture with ... |
| - | Pharmaceutical giant Sanofi invests $180 million in French medical research platform Owkin | Parisian AI biotech startup Owkin has received a $180 million investment from multi-national pharmaceutical giant Sanofi. As part of the investment, Owkin has also been awarded four exclusive collaborative cancer research projects, worth $9... |
| - | EU-backed healthcare project rolls out platform for federated learning in drug discovery | The three-year project MELLODDY, which had received €18-million from the European Union and partnering EFPIA companies under the Innovative Medicines Initiative (IMI2), has now built a secure platform for privacy-preserving and federated le... |
| - | French AI biotech startup Owkin gets $80-million shot from Bristol Myers Squibb to accelerate drug development | Parisian AI biotech unicorn Owkin has brought in $80 million as it partners with the US-based pharmaceutical giant Bristol Myers Squibb on drugs trials. The new partnership could be transformational for patient outcomes and scientific progr... |
| - | Which New York City healthcare companies raised the most dough from investors in Q2? | A new report from New York City Health Business Leaders found that during the second quarter of 2018, investors poured more than $300 million into healthcare startups based in the Big Apple.
The investment update also provides a closer look... |
| - | Decentralized research platform Owkin raises another $18M for series A | A startup building a platform for decentralized research rounded out its series A round with another $18 million in capital.
Owkin, which has its headquarters in New York and Paris, is building a research network using federated learning, a... |
| - | Owkin Raises $25M to Enhance Medical Research Machine Learning and Collaboration | 344SHARES
FacebookTwitter
Linkedin
Imagine what a collaborative platform like Google Docs would look like for researchers at hospitals, universities, and pharmaceutical companies and you can begin to understand the potential of Owkin and it... |
| - | OWKIN initiates AI research network made up of 44 organizations | OWKIN, a New York City-based company that provides machine learning tools for medical research purposes, has launched an AI-powered network comprised of 44 hospitals and research institutions in the United States and Europe. Members include... |
| - | Owkin | “Transforming research with agentic reasoning to create biological artificial superintelligence.” |
| - | Sanofi makes $270M bet that a startup’s AI tech can boost its cancer drug R&D | Sanofi wants to see how digital technologies can improve its cancer drug research and it’s committing $270 million to artificial intelligence and precision medicine startup Owkin to begin a multi-drug alliance.
Under the deal, Sanofi will u... |
